Page last updated: 2024-11-04

sarpogrelate and Obesity

sarpogrelate has been researched along with Obesity in 2 studies

sarpogrelate: structure given in first source

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kataoka, H1
Ariyama, Y1
Deushi, M1
Osaka, M1
Nitta, K1
Yoshida, M1
Nonogaki, K1
Nozue, K1
Oka, Y1

Other Studies

2 other studies available for sarpogrelate and Obesity

ArticleYear
Inhibitory Effect of Serotonin Antagonist on Leukocyte-Endothelial Interactions In Vivo and In Vitro.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Animals; Cell Adhesion; Cell Communication; Cell Line; Endothelial Cells; Endothelium, Vascular; Hum

2016
Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.
    Biochemical and biophysical research communications, 2006, Dec-29, Volume: 351, Issue:4

    Topics: Adiponectin; Animals; Appetite; Body Weight; Eating; Gene Expression; Hypothalamus; Male; Mice; Mice

2006
chemdatabank.com